Financials
Financial year 2025
Oncolo-Co from Vorst, company number BE0780358961, closed financial year 2025 with a result of € 2,011 after tax. For that financial year Oncolo-Co recorded a gross margin of € 190,929 and equity of € 7,616. Compared with financial year 2024, the result moved from € 1,139 to € 2,011. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on October 16, 2026.
€ 7,616
▲ € 12,011 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 2,011
▲ 77% vs 2024
Profit after tax over the fiscal year.
€ 77,768
▲ 151% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -4,884.
People and assets in 2025
€ 125,617
▼ 41% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 983,586
▼ 6% vs 2024
€ 64,660 is repaid this year. At this pace the long-term loan is gone in ≈ 15 years.
€ 803
▼ 89% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 4,538
▲ 33% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | - | € 165,874 | - | - | |
| Gross margin | € 30,303 | € 79,418 | € 172,472 | € 190,929 | ▲ 11% |
| Profit after taxes | € 15,083 | € -23,116 | € 1,139 | € 2,011 | ▲ 77% |
| Equity | € 17,583 | € -5,534 | € -4,395 | € 7,616 | ▲ € 12,011 |
| Total debts | € 27,064 | € 1,068,978 | € 1,051,917 | € 1,046,011 | ▼ 1% |
| Cash | € 1,099 | € 17,072 | € 31,044 | € 77,768 | ▲ 151% |
| Land & buildings | - | € 1,192,214 | € 1,157,681 | € 1,125,304 | ▼ 3% |
| Retained profit | € 15,083 | € -8,034 | € -6,895 | € -4,884 | ▲ € 2,011 |
| Bank debt | € 6,105 | € 1,033,114 | € 1,040,866 | € 983,586 | ▼ 6% |
| Balance sheet total | € 44,647 | € 1,579,111 | € 1,554,522 | € 1,560,628 |
Key figures of Oncolo-Co, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Oncolo-Co?
What happened at Oncolo-Co in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 2,011 (▲ 77% vs 2024). filed late Source: NBB ↗
- New establishment in Antwerpen. KBO
- Start of the company according to the CBE. KBO
- Vincent GELDHOF became a director. NBB
In short
From € 15,083 profit in 2022 to € 2,011 profit in 2025.
Paid € 17,633 in corporate taxes since 2022.
Best year ever: 2022, with € 15,083 profit.
Management
Behind Oncolo-Co is Vincent GELDHOF.
Directors
According to the 2025 annual accounts
Vincent GELDHOF
Director
since 2022
Establishments
Establishment units
Physical locations of this company
Besmelaan 103
1190 Vorst
Lange Gasthuisstraat 13 box 202
2000 Antwerpen
Active since 12 January 2022
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0780.358.961
- VAT number
- BE 0780.358.961
- Registered office
- Besmelaan 103, 1190 Vorst
- Names & denominations
- Oncolo-Co
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 12 January 2022
- Peppol
- Active · Active since 3 Oct 2026
- Activities · NACE
Activiteiten van medisch specialisten